Stay updated on Tepotinib Phase II Clinical Trial

Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib Phase II Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a '403 Forbidden' message and a Home button, replacing the previous study details and navigation. This blocks access to the trial information presented on that page.
    Difference
    17%
    Check dated 2026-09-23T01:11:13.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, indicating a new deployed version of the page. This change affects only deployment metadata, not the study details themselves.
    Difference
    0.0%
    Check dated 2026-09-16T00:07:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.6.6, replacing v3.6.5. This indicates a new build of the page without altering the study details.
    Difference
    0.0%
    Check dated 2026-09-01T19:12:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new NIH funding identifier, '2015 (U.S. NIH Grant/Contract)', was added to the study's identifiers on the Study Details page, documenting the funding source.
    Difference
    0.0%
    Check dated 2026-08-25T21:51:31.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small backend/frontend update to the study listing page.
    Difference
    0.0%
    Check dated 2026-08-11T18:46:40.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    New cross-registry identifiers from China and Japan registries were added (CTR20192576, jRCT2080223315, Japic CTI-163370) and the study revision updated to v3.6.4. Older identifiers and the previous revision (v3.6.3) were removed.
    Difference
    0.2%
    Check dated 2026-07-21T12:53:27.000Z thumbnail image

Stay in the know with updates to Tepotinib Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.